Gadopentetate Dimeglumine Injection

[Indications]
It is suitable for contrast-enhanced magnetic resonance imaging (MRI) of the central nervous system (brain and spine) and other body regions to improve the detection and characterization of lesions.

[Usage and dosage]
This product is administered by intravenous injection. The recommended dose for adults and pediatric patients is 0.1 mmol/kg body weight (equivalent to 0.2 mL/kg of the injection solution). The injection should be administered as a bolus injection or a slow intravenous injection. Additional doses may be given according to clinical requirements, but the total dose should not exceed 0.3 mmol/kg. Adequate hydration should be maintained before and after administration, especially in patients with renal impairment.